Answers are grounded in this paper and cite their sources.
fx1 Introduction: The longitudinal validity of the RADAR score for predicting short-term risk in primary care remains unestablished. We aimed to evaluate its prognostic performance for adverse events and to describe short-term changes in control status and patient-reported health status in a real-world prospective cohort. Methods: In this multicenter study, 706 primary care patients with COPD receiving maintenance triple therapy were assessed at baseline and after a median follow-up of 91 days. We analyzed the association between baseline RADAR control status (≥4 vs <4) and 3-month outcomes (all-cause mortality, severe exacerbations, moderate exacerbations, and composite events). We also described 3-month changes in RADAR score (ΔRADAR) and COPD Assessment Test score (ΔCAT). Results: Baseline poor control (RADAR ≥4) was strongly associated with severe exacerbations (16.2% vs 4.9%; OR, 3.75) and composite events (33.8% vs 22.9%; OR, 1.72). No significant difference was observed for moderate exacerbations (18.0% vs 18.9%). However, when modeled as a frequency count, each 1-point increase in RADAR score was associated with a 21% higher rate of moderate exacerbations (incidence rate ratio, 1.21; 95%CI, 1.15–1.27; P < .001). Patients with RADAR ≥4 exhibited a high-risk profile characterized by worse airflow limitation, active smoking, higher symptom burden, and poorer adherence. Over 3 months, significant changes were observed in the distributions of both ΔCAT and ΔRADAR when analyzed by clinical phenotype and risk level. Conclusions: The RADAR score effectively predicts short-term clinical risk in primary care and provides a practical tool for monitoring COPD and guiding clinical decision-making. It demonstrates significant prognostic value for identifying patients at high short-term risk of severe exacerbations and serves as an initial risk stratification tool to identify individuals requiring further assessment. The observed short-term changes highlight the dynamic nature of COPD control.
No takes yet. Share an insight, caveat, or question.
Rubio et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: